Skip to main content
Sister Publication Links
  • ESG: THE NEW IMPERATIVE
Subscribe
  • My Account
  • Login
  • Subscribe
  • News
    • Current News
    • COVID-19
    • Providers
    • Insurance
    • Government
    • Finance
    • Technology
    • Safety & Quality
    • Transformation
    • People
    • Regional News
    • Digital Edition (Web Version)
    • Patients
    • Operations
    • Care Delivery
    • Payment
    • Midwest
    • Northeast
    • South
    • West
  • Digital Health
  • Insights
    • ACA 10 Years After
    • Best Practices
    • Special Reports
    • Innovations
  • Data/Lists
    • Rankings/Lists
    • Interactive Databases
    • Data Points
  • Op-Ed
    • Bold Moves
    • Breaking Bias
    • Commentaries
    • Letters
    • Vital Signs Blog
    • From the Editor
  • Awards
    • Nominate/Eligibility
    • 100 Most Influential People
    • 50 Most Influential Clinical Executives
    • Best Places to Work in Healthcare
    • Excellence in Governance
    • Health Care Hall of Fame
    • Healthcare Marketing Impact Awards
    • Top 25 Emerging Leaders
    • Top 25 Innovators
    • Diversity in Healthcare
    • Women in Healthcare
    • - Luminaries
    • - Top 25 Diversity Leaders
    • - Leaders to Watch
    • - Luminaries
    • - Top 25 Women Leaders
    • - Women to Watch
  • Events
    • Conferences
    • Galas
    • Virtual Briefings
    • Webinars
    • Custom Media Event: ESG Summit
    • Transformation Summit
    • Women Leaders in Healthcare Conference
    • Social Determinants of Health Symposium
    • Leadership Symposium
    • Health Care Hall of Fame Gala
    • Top 25 Women Leaders Gala
    • Best Places to Work Awards Gala
    • Top 25 Diversity Leaders Gala
    • - Hospital of the Future
    • - Value Based Care
    • - Supply Chain Revenue Cycle
    • - Hospital at Home
    • - Workplace of the Future
    • - Strategic Marketing
    • - Virtual Health
  • Listen
    • Podcast - Next Up
    • Podcast - Beyond the Byline
    • Sponsored Podcast - Healthcare Insider
    • Video Series - The Check Up
    • Sponsored Video Series - One on One
  • MORE +
    • Advertise
    • Media Kit
    • Newsletters
    • Jobs
    • People on the Move
    • Reprints & Licensing
MENU
Breadcrumb
  1. Home
  2. Politics & Policy
August 29, 2021 08:50 PM

U.S. intelligence still divided on origins of coronavirus

Associated Press
  • Tweet
  • Share
  • Share
  • Email
  • More
    Reprints Print
    Dan DeLong for KHN
    A clinical lab technician at the UW Medicine Virology laboratory in Seattle processes patient samples for COVID-19 on March 11, 2020.

    U.S. intelligence agencies remain divided on the origins of the coronavirus but believe China's leaders did not know about the virus before the start of the global pandemic, according to results released Friday of a review ordered by President Joe Biden.

    According to an unclassified summary, four members of the U.S. intelligence community say with low confidence that the virus was initially transmitted from an animal to a human. A fifth intelligence agency believes with moderate confidence that the first human infection was linked to a lab. Analysts do not believe the virus was developed as a bioweapon and most agencies believe the virus was not genetically engineered.

    The Office of the Director of National Intelligence said in a statement Friday that China "continues to hinder the global investigation, resist sharing information and blame other countries, including the United States." Reaching a conclusion about what caused the virus likely requires China's cooperation, the office said.

    The cause of the coronavirus remains an urgent public health and security concern worldwide. In the U.S., many conservatives have accused Chinese scientists of developing COVID-19 in a lab and allowing it to leak. State Department officials under former President Donald Trump published a fact sheet noting research into coronaviruses conducted at the Wuhan Institute of Virology, located in the Chinese city where the first major known outbreak occurred.

    The scientific consensus remains that the virus most likely migrated from animals in what's known as a zoonotic transmission. So-called "spillover events" occur in nature, and there are at least two coronaviruses that evolved in bats and caused human epidemics, SARS1 and MERS.

    In a statement, Biden said China had obstructed efforts to investigate the virus "from the beginning."

    "The world deserves answers, and I will not rest until we get them," he said. "Responsible nations do not shirk these kinds of responsibilities to the rest of the world."

    China's embassy in Washington hit back with a lengthy statement saying the U.S. had "fabricated" the report and invoking mistaken American intelligence about weapons of mass destruction prior to the Iraq War.

    "The report by the intelligence community is based on presumption of guilt on the part of China, and it is only for scapegoating China," the embassy said. "Such a practice will only disturb and sabotage international cooperation on origin-tracing and on fighting the pandemic, and has been widely opposed by the international community."

    Biden in May ordered a 90-day review of what the White House said was an initial finding leading to "two likely scenarios": an animal-to-human transmission or a lab leak. The White House said then that two agencies in the 18-member intelligence community leaned toward the hypothesis of a transmission in nature and another agency leaned toward a lab leak.

    The Office of the Director of National Intelligence on Friday did not identify which agencies supported either hypothesis. But it noted some of the same hurdles facing the World Health Organization and scientists worldwide: a lack of clinical samples and data from the earliest cases of COVID-19.

    In conducting the review, intelligence agencies consulted with allied nations and experts outside of government. An epidemiologist was brought into the National Intelligence Council, a group of senior experts that consults the head of the intelligence community.

    Letter
    to the
    Editor

    Send us a letter

    Have an opinion about this story? Click here to submit a Letter to the Editor, and we may publish it in print.

    Recommended for You
    mh_20151012p29-Share-of-guns_i.jpg
    Northwell, Kaiser Permanente execs join CEOs backing gun legislation
    insulin_getty_sized_i_i_i.jpg
    California wants to slash insulin prices by becoming a drugmaker. Can it succeed?
    Sponsored Content
    Modern Healthcare Alert: Sign up for this breaking news email to be kept in the loop as urgent healthcare business news unfolds.
    Get Newsletters

    Sign up for enewsletters and alerts to receive breaking news and in-depth coverage of healthcare events and trends, as they happen, right to your inbox.

    Subscribe Today
    MH Magazine Cover

    MH magazine offers content that sheds light on healthcare leaders’ complex choices and touch points—from strategy, governance, leadership development and finance to operations, clinical care, and marketing.

    Subscribe
    Connect with Us
    • LinkedIn
    • Twitter
    • Facebook
    • RSS

    Our Mission

    Modern Healthcare empowers industry leaders to succeed by providing unbiased reporting of the news, insights, analysis and data.

    Contact Us

    (877) 812-1581

    Email us

     

    Resources
    • Contact Us
    • Advertise with Us
    • Ad Choices Ad Choices
    • Sitemap
    Editorial Dept
    • Submission Guidelines
    • Code of Ethics
    • Awards
    • About Us
    Legal
    • Terms and Conditions
    • Privacy Policy
    • Privacy Request
    Modern Healthcare
    Copyright © 1996-2022. Crain Communications, Inc. All Rights Reserved.
    • News
      • Current News
      • COVID-19
      • Providers
      • Insurance
      • Government
      • Finance
      • Technology
      • Safety & Quality
      • Transformation
        • Patients
        • Operations
        • Care Delivery
        • Payment
      • People
      • Regional News
        • Midwest
        • Northeast
        • South
        • West
      • Digital Edition (Web Version)
    • Digital Health
    • Insights
      • ACA 10 Years After
      • Best Practices
      • Special Reports
      • Innovations
    • Data/Lists
      • Rankings/Lists
      • Interactive Databases
      • Data Points
    • Op-Ed
      • Bold Moves
      • Breaking Bias
      • Commentaries
      • Letters
      • Vital Signs Blog
      • From the Editor
    • Awards
      • Nominate/Eligibility
      • 100 Most Influential People
      • 50 Most Influential Clinical Executives
      • Best Places to Work in Healthcare
      • Excellence in Governance
      • Health Care Hall of Fame
      • Healthcare Marketing Impact Awards
      • Top 25 Emerging Leaders
      • Top 25 Innovators
      • Diversity in Healthcare
        • - Luminaries
        • - Top 25 Diversity Leaders
        • - Leaders to Watch
      • Women in Healthcare
        • - Luminaries
        • - Top 25 Women Leaders
        • - Women to Watch
    • Events
      • Conferences
        • Transformation Summit
        • Women Leaders in Healthcare Conference
        • Social Determinants of Health Symposium
        • Leadership Symposium
      • Galas
        • Health Care Hall of Fame Gala
        • Top 25 Women Leaders Gala
        • Best Places to Work Awards Gala
        • Top 25 Diversity Leaders Gala
      • Virtual Briefings
        • - Hospital of the Future
        • - Value Based Care
        • - Supply Chain Revenue Cycle
        • - Hospital at Home
        • - Workplace of the Future
        • - Strategic Marketing
        • - Virtual Health
      • Webinars
      • Custom Media Event: ESG Summit
    • Listen
      • Podcast - Next Up
      • Podcast - Beyond the Byline
      • Sponsored Podcast - Healthcare Insider
      • Video Series - The Check Up
      • Sponsored Video Series - One on One
    • MORE +
      • Advertise
      • Media Kit
      • Newsletters
      • Jobs
      • People on the Move
      • Reprints & Licensing